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Abstract
The transcription factor spalt4 is a key early-response gene in otic placode induction. Here, we
characterize the cis-regulatory regions of spalt4 responsible for activation of its expression in the
developing otic placode and report the isolation of a novel core enhancer. Identification and
mutational analysis of putative transcription factor binding sites reveal that Pea3, a downstream
effector of FGF signaling, and Pax2 directly activate spalt4 during ear development. Morpholino-
mediated knock-down of each factor reduces or eliminates reporter expression. In contrast, combined
over-expression of Pea3 and Pax2 drives ectopic reporter expression, suggesting that they function
synergistically. These studies expand the gene regulatory network underlying early otic development
by identifying direct inputs that mediate spalt4 expression.
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Introduction
Ectodermal placodes are transient regions of thickened ectoderm of the head that contribute to
the ear, nose, lens and cranial ganglia (Baker and Bronner-Fraser, 2001). Of these, the best
studied is the otic placode, which is induced adjacent to the hindbrain by signals emanating
from flanking tissues (Dominguez-Frutos et al., 2009; Kil et al., 2005; Kwon and Riley,
2009; Ladher et al., 2005; Park and Saint-Jeannet, 2008). Signals such as FGFs (Leger and
Brand, 2002; Maroon et al., 2002; Vendrell et al., 2000; Wright and Mansour, 2003) Wnts
(Freter et al., 2008; Ohyama et al., 2006) and BMPs (Kwon and Riley, 2009) are involved in
otic placode induction (Martin and Groves, 2006) and activate specific patterns of gene
expression (Litsiou et al., 2005). For example, over-expression of FGFs induces ectopic otic-
like structures (Alvarez et al., 2003; Kil et al., 2005; Vendrell et al., 2000), while mutations in
FGFs lead to defects in ear development (Alvarez et al., 2003; Ladher et al., 2005). Following
induction, the columnar placode invaginates to form the otic vesicle, which subsequently
differentiates into the complex inner ear, including the cochlea, vestibular system and
endolymphatic sac.
The transcription factor spalt4, homolog of human SALL4 (Sweetman and Munsterberg,
2006), displays the correct localization pattern to be a key early-response gene in placode
induction in the chick (Barembaum and Bronner-Fraser, 2007). It is initially expressed
uniformly throughout the head ectoderm, overlapping with Six-Eya-Dach in the preplacodal
domain. It then resolves to the presumptive otic and olfactory placode regions by stage 10, as
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non-placodal ectoderm loses competence to form otic placode (Baker and Bronner-Fraser,
2001; Groves and Bronner-Fraser, 2000). Expression of spalt4 in non-placodal ectoderm is
sufficient to induce invagination or ingression and expression of a number of otic genes
(Barembaum and Bronner-Fraser, 2007). Interestingly, the effects of its gain- and loss-of-
function resemble those of FGF over-expression and mutations, respectively. This raises the
intriguing possibility that spalt4 may be downstream of FGF and other inductive signals.
Numerous transcription factors in addition to spalt4, including Pax2 (Mackereth et al., 2005)
Dlx3 (Esterberg and Fritz, 2009) and Dlx5 (Brown et al., 2005; Robledo and Lufkin, 2006),
have been found to play important roles in otic development (Baker and Bronner-Fraser,
2001). Although the position and function of a few of these regulators are documented in otic
development, their order, interrelationship and direct or indirect nature of their interactions are
not yet known and currently under investigation (Esterberg and Fritz, 2009; Hans et al.,
2007).
To better understand important gene regulatory interactions underlying ear development, we
set out to characterize the cis-regulatory regions of spalt4 based on its key position in otic
placode induction. We report the isolation and dissection of a novel spalt4 regulatory module,
responsible for activation of spalt4 expression in the developing otic placode. We further
interrogate this regulatory region to identify putative transcription factor binding sites and
upstream regulators controlling its expression. The results reveal that Pea3, a downstream
effector of FGF signaling, and Pax2 directly activate spalt4 during ear development. These
studies expand our knowledge of known transcription factors and their direct interactions
during development of the ear.
Materials and Methods
Cloning
Regions of non-coding genomic DNA in the vicinity of the spalt4 (Sall4) coding region were
compared between chick and other vertebrates. Conserved regions were amplified from the
BAC clone CH261-71D2 (BPRC, Oakland Research Institute, Oakland CA) and cloned into
the pTK vector in front of a minimal TK promoter driving GFP expression (Uchikawa et al.,
2004). Mutations were made by fusion PCR (Heckman and Pease, 2007). For over-expression
experiments, the protein coding regions of chicken Pea3 and Pax2 were amplified by RT-PCR
and cloned into the pCIG vector. Cerulean fluorescent protein was cloned into the pCAGS
expression vector.
Electroporation
Stage 4–6 embryo were collected on Whatman filter rings and placed ventral side up in an
electoporation chamber, with negative electrode at the bottom. Plasmid DNA, either at 1 mg/
ml for enhancer constructs or 2 mg/ml for over expression constructs, was injected through the
blastoderm into the space between the embryo and the vitelline membrane. The positive
electrode was placed above the embryo and an electric current was applied of 4 pulses of 7
volts, 50 msec in duration with a 100 msec pause in between pulses. After electroporation,
embryos were transferred ventral side up to a 35 mm dish with a thin layer of egg albumin at
the bottom and incubated in a humidified incubator at 37° C for 24 h (Sauka-Spengler and
Barembaum, 2008). Those embryos with high levels of fluorescence, indicating efficient
eletroporation, were fixed in 4% formaldehyde overnight. Morpholino oligos were obtained
from Gene-Tools (Philomath, OR) and dissolved in water at 1 mM or 3 mM concentrations.
Plasmid DNA (pUC19) was added at a final concentration of 100 ng/µl prior to injecting into
embryos. In order to electroporate the morpholino at 3 mM, the embryos were first
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electroporated with the enhancer construct then followed by the morpholino. The
fluoresceinated morpholino oligos were made with the following sequence:
Pea3: 5’-CTG CTG GTC CAC GTA CCC CTT CAT C-3’
Pax2: 5’-GTC TGC CTT GCA GTG CAT ATC CAT G-3’
Control: 5’-CCT CTT ACC TCA GTT ACA ATT TAT A-3’
Implantation of beads
Stage 4 embryos were collected on Whatman filter paper rings and turned ventral side up in
Ringer’s solution and electroporated as described above. A small slit was made in the area
opaca next to the area pellucida (Litsiou et al., 2005). A bead soaked in 50 ug/ml Fgf8 (R&D
Systems, Minneapolis MN) or BSA (bovine serum albumin) was inserted into the slit and
incubated in modified New culture (Chapman et al., 2001) for 5–7 hours and then collected
and fixed overnight in 4% paraformaldehyde.
Analysis of embryos
Embryos were collected in Ringer’s solution and fixed in 4% paraformaldehyde overnight.
Embryos were washed in PBT and embedded in gelatin for histochemical analysis or
dehydrated in methanol for in situ hybridization. In situ hybridization was performed as
described previously (Wilkinson, 1992). Antibodies to GFP (Abcam), Pax2 (Zymed), and
fluorescein (Roche) were obtained commercially. Primary antibodies were visualized with
Alexa Fluor 488-conjugated donkey anti-goat or Alexa Fluor 594-conjugated donkey anti-
rabbit secondary antibodies (Molecular Probes). Cerulean fluorescent protein expression was
distinguished from fluorescein signal using a Zeiss 510 META 2 inverted microscope.
Results
Dissection of putative spalt4 regulatory region
Spalt4 is initially expressed throughout the preplacodal domain but resolves to the otic placode
by stage 9–10 (Fig. 1A) (Barembaum and Bronner-Fraser, 2007). By stage 14, it is robustly
expressed in the otic pit and maintained during formation of the otic vesicle (Fig.1B). We set
out to identify enhancer elements capable of driving reporter expression that recapitulated this
spatiotemporal expression pattern.
To identify the cis-regulatory elements responsible for spalt4 expression in developing ear, we
probed the genomic region surrounding the spalt4 gene using comparative genomic analysis
to isolate highly conserved genomic regions with putative regulatory activity. For our study,
non-coding genomic regions in the upstream of the spalt4 coding region and the first intron
were compared in silico using the UCSC gene browser (Fig. 2A) (Karolchik, et al., 2008).
Fragments 1 kb to 5 kb in size containing the putative regulatory regions with the highest
homology were amplified from a chicken BAC clone and cloned into an EGFP reporter vector
containing a thymidine kinase basal promoter (Uchikawa et al., 2004).
The spalt4 gene is located on chicken chromosome 20 between genes ZFP64 and ATP9A.
Because the May 2006 version of the chicken genome did not contain the sequence of the first
exon, we cloned the DNA corresponding to a gap in the sequence from a BAC using GC rich
PCR. This region contained the first exon of spalt4. At the 5’ end there is over 100 kb of
sequence between spalt4 and ZFP64. We cloned several conserved regions upstream of the
coding region, as well as in the first intron, which induced GFP expression in various regions
of the embryo. These were denoted Conserved Region (CR) A–I (Fig. 2A).
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To test if the conserved genomic regions were functional in vivo, they were individually
electroporated into stage 4 chick embryos using an ex ovo technique (Uchikawa et al., 2004).
Electroporation efficiency was assessed by co-electroporating a pCIG mRFP plasmid construct
under control of a ubiquitous promoter. Embryos were collected 24–48 hrs (stages 10–20) after
electroporation, fixed and analyzed for EGFP expression using fluorescence microscopy. Of
the genomic regions analyzed, 13 had some enhancer activity, described below, though only
CR-F had expression in the otic placode (Fig. 2B–G).
Identification of spalt4 genomic fragment with regulatory activity in the developing otic
placode and other embryonic locations
The 1.3 kb fragment CR-F was conserved between chicken and mammals, but displayed no
conservation with Xenopus or zebrafish. When electroporated into chicken embryos, CR-F
drove GFP expression in the otic placode at stage 10 (Fig. 2C,D) with continued to be
expression in the otic pit (Fig. 2E) and later in the otic vesicle (Fig. 2F,G) at least until stage
17. GFP was observed in the otic region as well as the contiguous lateral ectoderm that will
give rise to the epibranchial placodes (Fig 2F,G). In addition it drove expression in the lateral
plate mesoderm (Fig. 2B–E) and midbrain (Fig. 2F). The GFP in lateral plate mesoderm, which
includes both the somatic and splanchnic mesoderm was expressed at least as early as stage 8
and included the heart field (Fig. 2A). The expression of GFP then became restricted caudally,
so that it was only seen in the caudal trunk region at stage12 (Fig. 2E), but not in the developing
heart. after stage 9 (Fig 2B).
CR-A, CR-B, CR-E and CR-H induced GFP expression only in the blood islands, at the times
and regions tested (data not shown). Two conserved regions besides CR-F drove expression
of GFP in the trunk mesoderm. CR-89 was expressed in the intermediate mesoderm (Fig. 3A)
and later in the developing pronephros. CR-C induced strong GFP expression in the presomitic
mesoderm and the caudal somites (Fig. 3D). Several other conserved regions displayed
complex expression patterns in the neural tube. CR-101 drove expression in the caudal neural
tube, including the future hindbrain at stage 10, but only in the spinal cord at stage 12 and later
(Fig. 3B). CR-C induced GFP throughout the neural tube (Fig. 3C) until stage 12 after which
time GFP expression was reduced. CR-G expressed GFP in the midbrain, rostral hindbrain and
rostral spinal cord, as well as in the presomitic mesoderm (Fig. 3E). In sections, only the ventral
neural tube had GFP expression (data not shown). The most distal element, CR-I drove
expression of GFP in the neural tube, though significantly higher expression was found in the
hindbrain (Fig. 3F). Thus, much of the embryonic expression of spalt4 was recapitulated by
the combined activity of the isolated enhancers. However, we were unable to detect a neural
crest enhancer.
Dissection of the CR-F fragment reveals a minimal enhancer region
To better understand regulatory interactions underlying ear development, we further
interrogated the CR-F fragment to determine a minimal otic enhancer element. For this purpose,
we used PCR to generate a number of deletion constructs (Fig. 4). A highly conserved 752 bp
subfragment (F14) retained both otic and mesodermal expression, similar to intact CR-F.
Removing the 5’ 71 base pairs reduced GFP level in the otic placode and eliminated lateral
mesoderm expression. Removing the 200 base pairs at the 3’ end reduced the mesoderm
expression. Removing an additional 88 base pairs reduced the otic expression and eliminated
the mesodermal expression. Loss of both the 5’ 71 base pairs and 3’ 200 base pairs eliminated
all expression.
The minimal fragment found to drive strong otic expression was 551 bp in length. Otic
expression appears to depend on several regions spread along the length of this fragment. To
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determine putative transcription factor binding sites that could be tested by mutational analysis,
we turned to a bioinformatics analysis.
Identification of transcription factor binding sites in CR-F
Examination of the 752 bp conserved sequence of CR-F using the JASPAR database
(Wasserman and Sandelin, 2004) revealed a number of putative transcription factor recognition
sites (Fig. 5). Of those most relevant to otic development, we found several potential Pax2
binding sites, as well as a number of putative Ets transcription factor binding sites, several of
which are recognized by Pea3 type family members, known to act as downstream effectors of
FGF signaling (Raible and Brand, 2001; Roehl and Nusslein-Volhard, 2001). Since Pax2
(Groves and Bronner-Fraser, 2000) and Pea3 (Lunn et al., 2007) both are expressed early in
otic development, they represented good candidates for regulating expression of spalt4 in the
otic placode.
To test whether the putative Pax2 and the Pea3 binding sites are necessary for enhancer activity,
a number of mutations were made in a minimal enhancer element by replacing the putative
binding sequences by heterologous GFP sequences of the same size. The mutations were
performed in the deletion construct CR-F12 since it maintains otic expression, though the
mesodermal enhancer activity is reduced. We targeted both remaining Pea3 sites as well as
the two Pax2 sites (fig. 6A). Mutation of the upstream putative Pea3 site (MutH, nucleotides
142–147 in Fig. 5) resulted in loss of otic enhancer activity (Fig 6F–I). We noted a reduction
of otic enhancer activity by mutating the Pax2 sites (MutG, 348–358), but not the intervening
Pea3 site (351–358) (Fig. 6D,E). The requirement for both the upstream Pea3 site and the
Pax2 sites suggests a possible synergistic interaction between these two sites. If the F14 (1–
752) construct has the mutation that removes both of the Pax2 sites and the intervening Pea3
site, otic enhancer activity is retained (data not shown). This may be due to the presence of
additional transcription binding sites that also have activity. We determined that he Pea3 site
is required in the larger fragment (Fig. 6H,I). Interestingly, the enhancer activity in the midbrain
is unaffected by mutating the Pea3 site (data not shown). Mutations to other putative
recognition sites, Otx and Tcf/Lef, have little or no effect on otic enhancer activity. However,
these sites may be important for expression in other regions or at times other than those
examined.
Additionally, using the CR-F14 construct that contains the full conserved region, we have
identified a putative Tbx binding site (512–520) that is required for enhancer activity in the
lateral plate mesoderm. Mutating this region resulted in the loss of enhancer activity in the
lateral plate mesoderm (data not shown).
Ectopic FGF, Pea3 or Pax2 induce CR-F expression
The Ets transcription factors Pea3 and Erm are both expressed in the otic placode and are part
of the FGF signaling pathway (Lunn et al., 2007). To test if CR-F could be activated by FGF,
we inserted beads soaked in FGF8 in the area opaca adjacent to the area pellucida in stage 4
embryos that had been previously electroporated with a CR-F pTK construct. In these embryos,
the cells surrounding the beads expressed GFP, indicating that FGF can induce the activity of
the CR-F enhancer (Fig. 7). Previously, in situ hybridization revealed spalt4 transcripts were
induced in the cells surrounding FGF coated beads (Barembaum and Bronner-Fraser, 2007).
Electroporation of Pea3 over-expression construct together with the CR-F Cherry reporter
caused ectopic Cherry expression co-localized in the extraembryonic ectoderm with ectopic
Pea3 expression (Fig 8A,B). However, Pea3 overexpressing cells in the embryonic ectoderm
did not induce enhancer activity over the embryo. Thus the ability of Pea3 to induce enhancer
activity is limited.
Barembaum and Bronner-Fraser Page 5
Dev Biol. Author manuscript; available in PMC 2010 June 28.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
To further study the effect of Pax2 on CR-F induction in the ear, we elecroporated a Pax2
expression construct and a pTK construct using CR-F12 driving the expression of Cherry
fluorescent protein in the ectoderm. In these experiments, the reporter expression reflected the
extent of Pax2 misexpression in the extraembryonic ectoderm (Fig. 8C,D). We also noted
ectopic Cherry expression in the caudal hindbrain ectoderm, but did not detect cherry
fluorescent protein in the rostral head or in the trunk ectoderm. Ectopic Pax2 can thus drive
ectopic CR-F induction of GFP only in limited regions of the embryo. In situ hybridization
with a spalt4 mRNA probe showed that these regions with ectopic Pax2 and CR-F12 driven
cherry expression also expressed spalt4 transcript (Supplementary Figure 1A).
Since the mutation experiments show that both Pax2 and Pea3 binding sites are required for
CR-F12 activity, we co-electroporated Pax2 and Pea3 expression constructs along with the
reporter. This resulted in Cherry expression in cells expressing Pax2 and Pea3 at all
rostrocaudal levels, even in the trunk ectoderm that does not normally form sensory placode
cells (Fig. 8E–H). The combination of Pax2 and Pea3 misexpression yielded much broader
enhancer activity than the sum of the effects of Pax2 and Pea3 overexpression individually,
demonstrating synergism between Pax2 and Pea3 in CR-F enhancer activity.
Effects of Pea3 and Pax2 antisense morpholinos on CR-F expression and endogenous ear
development
To study the loss-of function effect of Pea3, we used a morpholino oligomer to knockdown
expression of Pea3 in the otic placode. Electroporation of 1 mM Pea3 morpholino, directly
tagged with fluorescein, along with the CR-F12 enhancer construct resulted in the profound
loss of enhancer activity (Fig. 9E–H) as well as defects in ear development. In contrast, embryos
electroporated with control morpholino plus CR-F12-Cherry retained enhancer activity (Fig
A–D) and normal appearing otic placodes.
The morpholino to Pax2 was effective at 3 mM concentrations, resulting in a reduction of Pax2
protein as assayed of using an anti-Pax2 antibody. Cells containing high levels of morpholino,
as determined by the amount of fluorescein signal, did not contain Pax2 protein (data not
shown). As expected, Pax2 morpholino resulted in some defects in ear development. The
placodes on the morpholino-electroporated side were much thinner than the untreated side, and
failed to invaginate. We noted that electroporations of 3 mM morpholino resulted in a decrease
of enhancer activity in control and experimental embryos (data not shown), likely due to the
high morpholino concentration reducing the efficiency of plasmid transfection. To circumvent
this problem, we electroporated the enhancer construct first, followed by the morpholino
electroporation. Cells that received high levels of Pax2 morpholino lacked strong F12 enhancer
activity (Fig. 9I–K). Since not every cell that is transfected with the morpholino is also
transfected by the enhancer construct we co-electroporated a ubiquitous Cerulean expression
construct with the F12 enhancer reporter followed by a second electroporation with the
fluorescein tagged Pax2 morpholino. We were able to detect that cells that had Cerulean
expression and fluorescein labeling had no expression from the F12 enhancer reporter. We also
found that most cells expressing Cerulean and Cherry did not have high levels of fluorescein
tagged Pax2 Morpholino (Fig. 9L–O). With control morpholino, however, many cells with
high levels of control fluorescein tag had high F12 enhancer activity (Fig. 9A–D). Thus, cells
that contain high levels of Pax2 morpholinos, lacking Pax2 protein, also lack enhancer activity,
whereas cells with lower levels of Pax2 morpholino, as seen by lower fluorescein levels, had
some reporter expression. Spalt4 in situ hybridization also show reduced expression in the otic
placode of the morphant embryos (Supplementary Fig. 1B). These results are consistent with
our experiments with the mutated Pax2 sites that show that Pax2 is necessary for CR-F
enhancer activity in the ear.
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DISCUSSION
In depth analysis of the conserved regulatory regions of a key early-response gene in placode
induction has provided important information regarding the gene regulatory inputs involved
in chick otic development. By dissecting the chick spalt4 enhancer, we show that the synergistic
input of two transcription factors, Pea3 and Pax2, drives spalt4 expression in the developing
otic placode. Spalt4, which itself plays a role in otic formation, is expressed early in the placode
and later in the otic vesicle. Like FGFs, ectopic spalt4 is sufficient to cause non-placodal
ectoderm to invaginate and form vesicles that express many of the genes characteristic of the
ear (Barembaum and Bronner-Fraser, 2007).
Precursors for all the paired sensory placodes, including the otic placode, are derived from the
preplacodal domain, a horseshoe shaped region surrounding the anterior neural plate and
marked by Six-Eya gene expression (Schlosser, 2006; Streit, 2007). Later, FGF signaling
induces ectodermal cells within the preplacodal region to form otic placode (Martin and
Groves, 2006). The source of inductive signals appears to emanate from both the hindbrain
(Kil et al., 2005; Park and Saint-Jeannet, 2008) and underlying mesoderm (Kwon and Riley,
2009; Ladher et al., 2005). Studies in several species show that FGFs have the proper
spatiotemporal distribution to be involved in otic placode induction (Schimmang, 2007). In
the chick, FGF8 (Ladher et al., 2005) and FGF19 (Ladher et al., 2000) are expressed in the
mesoderm and FGF3 in the hindbrain (Mahmood et al., 1996). Furthermore, adding ectopic
FGF3, 19 and 8 can induce ectopic vesicles and expand the otic vesicles (Kil et al., 2005;
Vendrell et al., 2000). Inhibition of FGF signaling blocks Pax2 expression (Martin and Groves,
2006) and knockdown of FGF8 or FGF3 reduces or eliminates the otic placode (Ladher et al.,
2005; Zelarayan et al., 2007). FGF signaling activates the Ets genes, Pea3 and Erm, through
the action of the MAP kinase ERK (Raible and Brand, 2001; Roehl and Nusslein-Volhard,
2001; Firnberg and Neubuser, 2002). Both Pea3 and Erm transcription factors are expressed
in the otic placode (Lunn et al., 2007), and thus may be involved in transcriptional control of
downstream genes.
Similarly, genes of the Pax2/5/8 family are expressed in the developing otic placode (Groves
and Bronner-Fraser, 2000; Lawoko-Kerali et al., 2002)(Pfeffer et al., 1998). In mice, Pax8 is
expressed earliest followed by Pax2. In zebrafish, loss of Pax8 leads to defects in otic induction
that are enhanced by also reducing FGF signaling; furthermore, loss of Pax8 combined with
loss of Pax2a and Pax2b results in loss of the otic vesicle (Mackereth et al., 2005). In zebrafish,
Pax 2 and Pax8 may be downstream of Foxi1 and Dlx3b (Hans et al., 2004). However, knockout
mice lacking Pax8 have no apparent otic phenotype (Mansouri et al., 1998), whereas Pax2
knockouts present agenesis of the cochlea and vestibuloacoustic ganglia (Torres et al., 1996).
The present results show that a non-coding region of spalt4 conserved between mammals and
birds (CR-F) is sufficient to drive reporter expression that recapitulates endogenous spalt4 in
the otic placode at stage 10 and later in the otic vesicle. Similarly, expression of spalt4 in the
CNS can be recapitulated by the sum of at least four separate conserved regions, each of which
is responsible for a distinct subset of expression patterns in the brain and spinal cord. There
are also three different regions that have enhancer activity in different mesodermal regions.
The CR-F region contains a number of consensus transcription factor binding sites for potential
regulators of otic placode genes: Pea3/Erm which are effectors of FGF signaling, Pax2 which
is expressed in the ectoderm prior to its thickening into the otic placode, and TCF-Lef which
is a component of the Wnt signaling pathway. While mutation of the TCF-Lef site had no
apparent effect on reporter expression, mutations of either the Pax2 sites or the upstream Pea3/
Erm site reduced or abolished enhancer activity in the otic placode and vesicle. Thus, each site
is necessary for activity and they appear to act synergistically.
Barembaum and Bronner-Fraser Page 7
Dev Biol. Author manuscript; available in PMC 2010 June 28.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
While we have shown that the Pax2 and Pea3/Erm binding sites are required, we cannot
exclude the possibility that other binding sites and other transcription factors are also involved
in activation of CR-F otic enhancer activity. To address whether the endogenous transcription
factors are required for the enhancer activity, we performed loss-of-function analysis.
Accordingly, a Pea3 morpholino completely eliminated enhancer activity. Similarly, cells
electroporated with high levels of the Pax2 morpholino also lacked CR-F activity. In addition,
both Pea3 and Pax2 morpholinos reduced the levels of the endogenous spalt4 mRNA. These
data are consistent with the mutational experiments in suggesting that Pea3 and Pax2 are direct
inputs to the CR-F enhancer.
Furthermore, Pea3 and Pax2 can induce CR-F activity when expressed in ectopic locations
such as the extraembryonic ectoderm. We can also detect CR-F activity in the hindbrain level
ectoderm caudal to the otic placode when Pax2 is over-expressed in this location. However,
many regions of the embryo, such as the trunk, do not have CR-F activity when Pax2 or
Pea3 are expressed by themselves. Simultaneous electroporation of both Pax2 and Pea3
expression constructs results in ectopic CR-F enhancer activity in the trunk ectoderm and
throughout the hindbrain level ectoderm. Thus, Pax2 and Pea3 together are sufficient to induce
ectopic CR-F throughout the embryo, whereas neither alone is sufficient. This supports the
idea that these two transcription factors act synergistically.
In summary, we have interrogated the regulatory region of a key gene involved in specification
of the otic placode. Our results place the synergistic interaction of Pax2 and Pea3 directly
upstream of spalt4, which in turn feeds back to activate Pax2 (Barembaum and Bronner-Fraser,
2007). Establishing direct inputs into the regulatory region of spalt4 that drives its otic
expression provides important insights into the gene regulatory network underlying induction
of the chick inner ear.
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Figure 1.
In situ hybridization of chicken embryos with spalt4 RNA probe. A. Stage 10 embryo showing
signal in the otic placode (arrowhead) and presomitic mesodem (arrow). B. Stage 14 embryo
showing signal in the otic pits (black arrowhead) and midbrain (arrow). The region that will
give rise to the epiphysis also expresses spalt4 (white arrowhead). Other forebrain staining is
background.
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Figure 2.
Isolation of conserved regions adjacent to chicken spalt4. A. Map of the region adjacent to
spalt4. The peaks show regions of conservation. The dark bands below each peak show the
regions conserved between chicken and each of the other species examined. The red letters
above each peak identify the regions that were cloned. Spalt4 coding region is at the extreme
right of the map. B–G. Enhancer activity of conserved region F (CR-F). B. At stage 9, CR-F
drives expression in the lateral plate mesoderm (arrowhead). C. At stage 10 CR-F drives GFP
in the otic placode (arrowhead). D. A section through a stage 10 embryo electroporated with
CR-F shows that the otic placode (arrowhead) and the lateral plate mesoderm express GFP.
E. Stage 12 embryo with GFP in the otic pits (arrowhead). F. Stage 14 embryo shows GFP
expression in the otic vesicle (arrowhead), epibranchial placodes (large arrow) and the
midbrain small (arrow). G. Section through a stage 14 embryo showing GFP expression in the
otic vesicles (arrowhead). Each embryo was co-electroporated with pCIG-RFP as an
electroporation control.
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Figure 3.
Enhancer activity in other mesoderm and neural tube. A. Conserved region 89 (CR-89) drove
GFP expression in the intermediate mesoderm (arrowhead). B. CR-101 in the caudal CNS
(arrowhead). C. CR-C in the neural tube (arrowhead). D. CR-D in the presomitic mesoderm
and the somites (arrowhead) E. CR-G in the midbrain (arrowhead) and the spinal cord (arrow).
F. CR-I drove expression most strongly in the hindbrain (arrowhead). Each embryo was co-
electroporated with pCIG-RFP as an electroporation control.
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Figure 4.
Deletions made to CR-F. The level of conservation is seen at the top. Each deletion is identified
by its location in the sequence in Figure 5. They were qualitatively assessed for their ability to
drive expression in the otic placode (otic) or lateral plate mesoderm (meso) to determine
whether they had the same level as the the full length (F14) construct, ++, had a reduced level,
+, or an undetectable level (−).
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Figure 5.
The sequence of CR-F14. Some of the consensus transcription factor recognition sites are
shaded for identification.
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Figure 6.
Mutational analysis of CR-F12. A. Two different mutation constructs were made. MutH had
a mutation in the Pea3 site located at 142–147. MutG mutated both Pax2 sites between 348
and 368 and the Pea3 site at 351–356 was not mutated (dotted line under the sequence).
Embryos were co-electroporated with the mutant constructs driving GFP (D,F,H) and non-
mutant constructs driving Cherry fluorescent protein (C, E, G,I) as controls. Arrows point to
the otic placode. B. Embryo electroporated with the non-mutated CR-F12 driving GFP had
otic expression. C. Embryo in (B) showing comparable levels of Cherry. D. MutG construct
showing much reduced levels of GFP in the otic compared to E. F. F12MutH construct had
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undetectable levels of GFP in the otic while the control had normal levels G. H. F14MutH had
undetectable levels of GFP in the otic, while the F14 control had normal levels I.
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Figure 7.
FGF8 induced CR-F activity. Embryos were electroporated with CR-F-pTK and pCIG-RFP.
Beads soaked in FGF8 (A,B) or BSA (C,D) were implanted in the area opaca. A. Ectoderm
above the FGF8 soaked beads (arrowheads) contained GFP. B. Same embryo as in (A) showing
broad RFP as an electroporation control. The positions of the beads are outlined. C. Ectoderm
above a BSA soaked bead (arrowhead) had no visible GFP positive cells. D. Same embryo as
in (C) showing the cells above the bead were electroporated (arrowhead). The position of the
bead is outlined.
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Figure 8.
Pea3 and Pax2 can induce CR-F activity in the extraembryonic ectoderm and together can
induce CR-F activity throughout the embryo. Embryos co-electroporated with Pea3pCIG and
CR-F12 cherry (A,B), Pax2pCIG and CR-F12 Cherry (C,D) and Pea3pCIG, Pax2pCIG and
CR-F12 cherry (E–H). A. Pea3 expressed throughout the embryo. B. Cherry driven by CR-F
was expressed in the otic placode and in the extraembryonic ectoderm (arrohead). C. Pax2 was
expressed throughout the embryo. D. Cherry driven by CR-F was expressed in the otic placode
and the extraembryonic ectoderm (arrowhead). E. G. combined expression of Pea3 and Pax2
throughout the ectoderm. F. H. Cherry driven by CR-F was detected in the trunk ectoderm
(arrow) as well as the extraembryonic ectoderm (arrowhead). (E) and (F) are lower
magnification pictures of the embryo in (G) and (H). The otic placode is outlined in (B), (D),
(F), and (H).
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Figure 9.
Morpholino oligos to Pax2 and Pea3 reduce CR-F activity in the otic placode. A. Fluorescein
in embryo treated with 3 mM control morpholino. B. Embryo in (A) showing CR-F enhancer
activity driving Cherry fluorescent protein expression. C. Higher magnification of (A) showing
cells with high levels of control morpholino (arrowhead). D. Same region as in (C) showing
the cells with high levels of control morpholino had high levels of CR-F activity (arrowhead).
E. Fluorescein in embryo treated with 1 mM Pea3 morpholino. F. Embryo in (E) showing CR-
F12 enhancer activity driving Cherry fluorescent protein expression. G. Higher magnification
of (A) showing cells with either high levels of Pea3 morpholino (arrowhead) or low levels
(arrow). H. Same region as in (G) showing the cells with high levels of Pea3 morpholino had
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low levels of CR-F activity (arrowhead) and cells with low levels of morpholino had high levels
of CR-F activity (arrow). I. Fluorescein in embryo treated with 3 mM Pax2 morpholino. J.
Embryo in (I) showing CR-F enhancer activity driving Cherry fluorescent protein expression.
K. Merged image of (I) and (J). Arrows in (I–K) show cells with high enhancer activity and
low levels of fluorescein tagged Pax2 morpholino. Arrowheads point to cells with high
morpholino levels and low enhancer activity. L-O. Embryo electroporated with F12Cherry
enhancer reporter construct and Cerulean ubiquitous expression vector followed by a second
electroporation with fluorescein tagged Pax2 morpholino and imaged with a Zeiss 510 META
inverted microscope. L. Fluorescein signal showing cells that contained the Pax2 morpholino.
M. Cherry signal showing cells that have F12 enhancer activity. N. Cerulean signal showing
the cells that were electroporated. O. Merged image of (L–M). Arrowheads in (L–O) point to
a cell that had high levels of fluorescein tagged morpholino had little enhancer activity though
still expressing Cerulean. Arrow points to a cell with high level of enhancer activity and
Cerulean expression, but had low levels of fluorescein tagged morpholino.
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